Merck & Co. Inc. closed 29.03% below its 52-week high of $134.63, which the company reached on June 25th.

Germany's Merck KGaA is betting on partnerships to boost its biopharma business. Speaking with Bloomberg TV on the sidelines ...

In a report released on January 21, Akash Tewari from Jefferies reiterated a Buy rating on Merck & Company (MRK – Research Report). The ...

The J&J deal would be the biggest biotech deal in over a year and will add treatments for disorders of the central nervous ...

Merck stock (NYSE: MRK) lost about 10% in 2024, underperforming the broader S&P 500 index, which gained 23% for the year.

President-elect Donald Trump's pick to lead HHS has a long history of discounting and peddling misinformation about the HPV ...

Berenberg Bank analyst Luisa Hector maintained a Buy rating on Merck & Company (MRK – Research Report) yesterday and set a price target of ...

Merck & Co's Covid-19 antivirals are getting ... companies including Henan Genuine Biotech Co., Simcere Pharmaceutical Group Ltd. and Shanghai Junshi Biosciences Co. A spokesperson for Merck ...

NEW YORK, NY - MAY 14: The MetLife corporate logo sits at the top of their building ... the policyholder account balances. The company’s group benefits business was a weak performer over the ...